StockData
Prothena Corp Public Ltd Co logo

Prothena Corp Public Ltd Co (PRTA) stock

PRTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3022% below fair value
$8.26+0.29 (+3.64%)

Close on Nov 17, 2026Market cap $424.04MP/E –Yield –

Prothena Corp Public pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Prothena Corp Public's pe ratio was 23.9× on Jul 29, 2022.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Jul 29, 202223.9×−24.1
2021Dec 31, 202148.0×–

More Prothena Corp Public figures

See a number that looks wrong?